Zhonggao Xu

1.5k total citations
48 papers, 1.0k citations indexed

About

Zhonggao Xu is a scholar working on Nephrology, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Zhonggao Xu has authored 48 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Nephrology, 11 papers in Molecular Biology and 7 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Zhonggao Xu's work include Chronic Kidney Disease and Diabetes (16 papers), Renal Diseases and Glomerulopathies (14 papers) and Dialysis and Renal Disease Management (4 papers). Zhonggao Xu is often cited by papers focused on Chronic Kidney Disease and Diabetes (16 papers), Renal Diseases and Glomerulopathies (14 papers) and Dialysis and Renal Disease Management (4 papers). Zhonggao Xu collaborates with scholars based in China, United States and South Korea. Zhonggao Xu's co-authors include Yanli Cheng, Wanning Wang, Weixia Sun, Lu Cai, Huanfa Yi, Zhanchuan Ma, Jinyu Yu, Hao Wu, Yong‐Guang Yang and Xiang‐Yang Wang and has published in prestigious journals such as Scientific Reports, International Journal of Molecular Sciences and Kidney International.

In The Last Decade

Zhonggao Xu

44 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhonggao Xu China 17 312 204 190 159 126 48 1.0k
Hong Luan China 20 528 1.7× 202 1.0× 114 0.6× 116 0.7× 111 0.9× 55 1.2k
Guoqiang Zhang China 17 397 1.3× 168 0.8× 165 0.9× 186 1.2× 83 0.7× 92 1.1k
Chen Yu China 23 498 1.6× 186 0.9× 358 1.9× 96 0.6× 93 0.7× 82 1.4k
Rongshuang Huang China 18 572 1.8× 162 0.8× 447 2.4× 168 1.1× 62 0.5× 34 1.3k
Chunling Huang China 21 565 1.8× 91 0.4× 200 1.1× 162 1.0× 70 0.6× 56 1.1k
Yu Ah Hong South Korea 18 415 1.3× 80 0.4× 459 2.4× 215 1.4× 127 1.0× 83 1.4k
Jiagen Wen China 19 515 1.7× 101 0.5× 211 1.1× 121 0.8× 97 0.8× 47 1.1k
Andy K. H. Lim Australia 12 392 1.3× 179 0.9× 499 2.6× 180 1.1× 69 0.5× 44 1.5k
Fares E.M. Ali Egypt 22 389 1.2× 101 0.5× 75 0.4× 138 0.9× 115 0.9× 68 1.1k
Jiefu Zhu China 23 622 2.0× 183 0.9× 412 2.2× 241 1.5× 69 0.5× 43 1.4k

Countries citing papers authored by Zhonggao Xu

Since Specialization
Citations

This map shows the geographic impact of Zhonggao Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhonggao Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhonggao Xu more than expected).

Fields of papers citing papers by Zhonggao Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhonggao Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhonggao Xu. The network helps show where Zhonggao Xu may publish in the future.

Co-authorship network of co-authors of Zhonggao Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Zhonggao Xu. A scholar is included among the top collaborators of Zhonggao Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhonggao Xu. Zhonggao Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yuan, Zengrong, Dan Dong, Zhang Li, & Zhonggao Xu. (2025). Telitacicept administration improved immunoglobulin A nephropathy after hematopoietic stem cell transplantation: a case report. Frontiers in Medicine. 12. 1667519–1667519.
2.
3.
4.
5.
Wu, Meiyan, Yanli Cheng, Jinyu Yu, et al.. (2024). Cathepsin S (CTSS) in IgA nephropathy: an exploratory study on its role as a potential diagnostic biomarker and therapeutic target. Frontiers in Immunology. 15. 1390821–1390821. 2 indexed citations
6.
Dong, Zheyi, Jianhui Zhou, Zhonggao Xu, et al.. (2023). Efficacy and Safety of Mizoribine for the Treatment of Refractory Nephrotic Syndrome: Protocol for a Multicenter, Controlled, Open-label, Randomized Controlled Trial. JMIR Research Protocols. 12. e46101–e46101. 1 indexed citations
7.
Zhang, Li, et al.. (2023). The Intestinal Microbiota Composition in Early and Late Stages of Diabetic Kidney Disease. Microbiology Spectrum. 11(4). e0038223–e0038223. 19 indexed citations
8.
Wang, Xueyao, et al.. (2023). Renal C4d is a potential biomarker of disease activity and severity in pediatric lupus nephritis patients. Frontiers in Pediatrics. 11. 1193917–1193917. 3 indexed citations
9.
Ma, Zhanchuan, et al.. (2023). Oxidative stress as a culprit in diabetic kidney disease. Life Sciences. 322. 121661–121661. 33 indexed citations
10.
11.
Wu, Meiyan, et al.. (2022). Hypoxia-inducible factor prolyl hydroxylase inhibitors for anaemia in maintenance dialysis: a meta-analysis. Clinical and Experimental Nephrology. 26(11). 1043–1054. 5 indexed citations
12.
Hou, Jie, Li Zhang, Hao Wu, Pujun Gao, & Zhonggao Xu. (2021). Increased Tim-3+ monocytes/macrophages are associated with disease severity in patients with IgA nephropathy. International Immunopharmacology. 97. 107666–107666. 5 indexed citations
13.
Zhang, Li, et al.. (2021). The common risk factors for progression and mortality in COVID-19 patients: a meta-analysis. Archives of Virology. 166(8). 2071–2087. 35 indexed citations
14.
Zhang, Li, et al.. (2020). Endothelin receptor antagonists for the treatment of diabetic nephropathy: A meta-analysis and systematic review. World Journal of Diabetes. 11(11). 553–566. 18 indexed citations
15.
Chen, Bin, et al.. (2019). Association Between IL-6 Polymorphisms and Diabetic Nephropathy Risk: A Meta-analysis. The American Journal of the Medical Sciences. 358(5). 363–373. 18 indexed citations
16.
Wang, Wanning, Weixia Sun, Yanli Cheng, Zhonggao Xu, & Lu Cai. (2019). Role of sirtuin-1 in diabetic nephropathy. Journal of Molecular Medicine. 97(3). 291–309. 110 indexed citations
17.
Wang, Wanning, Lu Cai, Paul N. Epstein, et al.. (2019). Sex differences in progression of diabetic nephropathy in OVE26 type 1 diabetic mice. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1866(1). 165589–165589. 16 indexed citations
18.
Ma, Fuzhe, Tao Sun, Meiyan Wu, Wanning Wang, & Zhonggao Xu. (2017). Identification of key genes for diabetic kidney disease using biological informatics methods. Molecular Medicine Reports. 16(6). 7931–7938. 10 indexed citations
19.
Wang, Wanning, et al.. (2016). Effect of peritoneal dialysis versus hemodialysis on renal anemia in renal in end-stage disease patients: a meta-analysis. Renal Failure. 39(1). 59–66. 7 indexed citations
20.
Vaziri, Nosratola D., et al.. (2005). Role of AT-1 receptor in regulation of vascular MCP-1, IL-6, PAI-1, MAP kinase, and matrix expressions in obesity. Kidney International. 68(6). 2787–2793. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hong Luan Breakdown of academic impact, for papers by Guoqiang Zhang Breakdown of academic impact, for papers by Chen Yu Breakdown of academic impact, for papers by Rongshuang Huang Breakdown of academic impact, for papers by Chunling Huang Breakdown of academic impact, for papers by Yu Ah Hong Breakdown of academic impact, for papers by Jiagen Wen Breakdown of academic impact, for papers by Andy K. H. Lim Breakdown of academic impact, for papers by Fares E.M. Ali Breakdown of academic impact, for papers by Jiefu Zhu
Rankless by CCL
2026